Complex interrelationship and therapeutic advances in diabetic patients with atrial fibrillation

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Diseases

Background:

• Diabetes mellitus and atrial fibrillation (AF) are prevalent global health issues.
• Diabetes is linked to increased AF incidence and poorer prognosis.

Purpose of the Study:

• To explore the intricate relationship between diabetes mellitus and atrial fibrillation.
• To review the pathophysiological mechanisms connecting these two conditions.
• To discuss current and emerging management strategies for patients with both conditions.

Main Methods:

• Literature review of pathophysiological mechanisms.
• Analysis of current management guidelines for AF in diabetic patients.
• Evaluation of novel antidiabetic therapies and their potential impact on AF outcomes.

Main Results:

• Key mechanisms include inflammation, oxidative stress, atrial remodeling, autonomic dysfunction, advanced glycation, and epicardial adiposity.
• Standard AF management (anticoagulation, rate/rhythm control) is crucial.
• Emerging antidiabetic drugs (SGLT2 inhibitors, GLP-1 RAs) may offer improved AF outcomes.

Conclusions:

• The coexistence of diabetes and AF presents significant clinical challenges.
• Understanding shared pathophysiological pathways is vital for effective management.
• Individualized treatment incorporating novel antidiabetic agents is essential to reduce morbidity and mortality.